YiChang HEC ChangJiang Pharmaceutical (HKG:1558) shares fell 4% Thursday afternoon after the company and Sunshine Lake Pharma announced an extension of the long-stop date for their proposed merger to Dec. 31, according to a Wednesday Hong Kong bourse filing.
The delay was attributed to the need for additional time to complete regulatory procedures.
In the statement, the companies said the China Securities Regulatory Commission had completed its filing process for the proposed listing of Sunshine Lake Pharma's H-shares. This partially fulfills one of the three preconditions for the merger by absorption.
However, approval from the Listing Committee of the Hong Kong bourse remains outstanding.
The long-stop date was extended to allow sufficient time for the vetting process to be completed by both the Hong Kong stock exchange and the Securities and Futures Commission.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。